Search Results - "Patil, Ketaki"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Retroperitoneal nonfunctional extraadrenal paraganglioma: A diagnostic challenge by Patil, Purwa, Khan, Wasif, Sengupta, Abhishek, Patil, Ketaki

    Published in Saudi Journal for Health Sciences (01-09-2021)
    “…Retroperitoneal nonfunctional extraadrenal paragangliomas are uncommon neoplasms arising from the aorticosympathetic chain of paraganglia. Biopsy of these…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone-releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix) by Bahl, Ankur, Rajappa, Senthil, Rawal, Sudhir, Bakshi, Ganesh, Murthy, Vedang, Patil, Ketaki

    Published in Indian journal of cancer (01-03-2022)
    “…Luteinizing hormone-releasing hormone agonist (LHRH-A), goserelin, and antagonist, degarelix, are both indicated for the treatment of advanced prostate cancer…”
    Get full text
    Journal Article
  4. 4

    Primary Vaginal Amelanotic Melanoma: A Diagnostic Conundrum by Patil, Purwa, Khan, Wasif Ali, Walke, Vaishali, Patil, Ketaki

    Published in Curēus (Palo Alto, CA) (29-12-2021)
    “…Primary vaginal amelanotic melanoma (PVAM) is an exceptionally rare aggressive malignancy having a poor prognosis. PVAM shows a high incidence of recurrence,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis by Viswanathan, Vinod K., Ghoshal, Aloke G., Mohan, Anant, Patil, Ketaki, Bhargave, Chaitanya, Choudhari, Sanjay, Mehta, Suyog

    Published in Pulmonary therapy (01-12-2024)
    “…A severe and progressive interstitial lung disease (ILD) known as idiopathic pulmonary fibrosis (IPF) has an unknown etiology with poorly defined mechanisms of…”
    Get full text
    Journal Article
  7. 7

    Gonadotropin-releasing hormone agonists in prostate cancer: A comparative review of efficacy and safety by Raja, T, Sud, Rahul, Addla, Sanjai, Sarkar, Kalyan, Sridhar, P, Talreja, Vikas, Jain, Minish, Patil, Ketaki

    Published in Indian journal of cancer (01-03-2022)
    “…Androgen deprivation therapy (ADT) using gonadotropin-releasing hormone agonist (s) (GnRH-A) remains the backbone of advanced prostate cancer treatment. In…”
    Get full text
    Journal Article
  8. 8